Immune responses against tumor associated antigens are induced by treatment with the cell-based tumor vaccine MGN1601 in patients with renal cell carcinoma

Category Primary study
JournalCancer Immunology Research
Year 2016
This article has no abstract
Epistemonikos ID: 2cfb6e672049a489c41dbcac5a9d74ea95615cd0
First added on: Feb 08, 2025